Prof. Hardy is a world-renowned neuroscientist who is the most-cited AD researcher in the UK. He received his BSc in Biochemistry from the University of Leeds in 1976 and his PhD in Neurochemistry from Imperial College London in 1981. He spent his early career at the University of Newcastle upon Tyne, Umeå University, and St Mary’s Hospital (which later merged with Imperial College London). Between 1989 and 2007, he worked in the US, taking up several senior positions at the University of South Florida, the Mayo Clinic in Florida, and the National Institute on Aging at the National Institutes of Health. Since 2007, he has been Professor of Neuroscience at UCL and is currently the Head of the Department of Molecular Neuroscience and the Chair of Molecular Biology of Neurological Disease at the UCL Queen Square Institute of Neurology.
Prof. Hardy was elected a Member of the UK Academy of Medical Sciences in 2008, a Fellow of the UK Royal Society in 2009, of the Institute of Biology (now known as the UK Royal Society of Biology) in 2011, and of the European Molecular Biology Organization in 2015. He was awarded a Doctor of Science honoris causa by HKUST in 2020.
He has received numerous international awards including the Dan David Prize (2014), the Thudichum Medal (2015), the Hartwig Piepenbrock-DZNE Prize (2015), and the Helis Prize (2016). In recognition of his pioneering research in neurodegeneration, he was awarded the prestigious Breakthrough Prize in Life Sciences in 2016 and the Brain Prize in 2018.